Untangling the difficult interplay between ischemic and hemorrhagic risk: The role of risk scores

Table 1 Ischemic risk scores items and OR/HR

Item	OR/HR (CI)
CHA2DS2-Vasc (OR)
Congestive HF	0.72 (0.27-1.88) NS
Hypertension	1.01 (0.38-2.66) NS
Age ≥ 65	NR
Age ≥ 75	1.46 (0.63-3.35) NS
Diabetes mellitus	1.79 (0.73-4.40) NS
Stroke	2.22 (0.78-6.35) NS
Vascular disease	2.27 (0.94-5.46) NS
Female sex	2.53 (1.08-5.92)
DAPT (OR)
Age, per 10 yr increase	1.54 (1.34-1.78) (on bleedings)
Current smoking	1.4 (1.11-1.76)
Diabetes mellitus	1.38 (1.1-1.72)
Acute coronary syndrome	1.65 (1.31-2.07)
PCI or prior ACS	1.79 (1.43-2.23)
Stent diameter < 3 mm	1.61 (1.3-1.99)
Paclitaxel stent	1.57 (1.26-1.97)
Congestive HF	1.88 (1.35-2.62)
Saphenous vein graft stenting	1.75 (1.13-2.73)
PARIS-CTE (HR)
Current smoking	1.69 (1.14–2.52)
CrCl < 60 mL/min	2.12 (1.46–3.05)
Diabetes mellitus
Non-insulin dependent	1.69 (1.14–2.52)
Insulin dependent	3.42 (2.32–5.04)
Acute coronary syndrome
Troponin negative	1.47 (1.03–2.08)
Troponin positive	2.09 (1.24–3.53)
Previous revascularization
Previous PCI	1.91 (1.38–2.66)
Previous CABG	1.80 (1.24–2.61)

CI: Confidence interval; CrCl: Creatinine clearance; HF: Heart failure; HR: Hazard ratio; NR: Not reported; NS: Not significant; OR: Odds ratio.